Cargando…
Fremanezumab for Migraine Prevention in Japanese Elderly Aged Over 70 Years Old
Background Elderly migraine is a public health problem with prolonged life expectancy, and effective prophylactic treatment is needed. There were no reports on fremanezumab for the elderly. We described the real-world data of fremanezumab, calcitonin gene-related peptide-related monoclonal antibody...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942430/ https://www.ncbi.nlm.nih.gov/pubmed/36824556 http://dx.doi.org/10.7759/cureus.34052 |